SCHEMBL3296223

SCHEMBL3296223

CCCCOc1cc(OCCCC)c([SiH](O[SiH](c2c(OCCCC)cc(OCCCC)cc2OCCCC)c2c(OCCCC)cc(OCCCC)cc2OCCCC)c2c(OCCCC)cc(OCCCC)cc2OCCCC)c(OCCCC)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NR5A1 Q13285 1/20 0.38
TSHR P16473 2/20 0.38
PLA2G2A P14555 1/20 0.38
TP53 P04637 1/20 0.38
TLR8 Q9NR97 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
PLA2G4B P0C869 2/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
AHR P35869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3296942 0.80 LTA4H (0.38) LTA4HCYP1A2CYP2C9CYP2C19NR5A1
SCHEMBL3297756 0.79 CYP1A2 (0.52) LTA4HCYP1A2CYP2C9CYP2C19TLR8
SCHEMBL3295354 0.79 LTA4H (0.43) LTA4HCYP1A2CYP2C9CYP2C19NR5A1
SCHEMBL3295211 0.79 NQO1 (0.41) LTA4HTSHRTP53TLR8CYP3A4
SCHEMBL3302675 0.77 PLA2G2A (0.43) LTA4HNR5A1TSHRPLA2G2ATP53
SCHEMBL3295598 0.76 LTA4H (0.44) LTA4HCYP1A2CYP2C9CYP2C19NR5A1
SCHEMBL6707482 0.76 LTA4H (0.44) LTA4HCYP1A2CYP2C9CYP2C19NR5A1
SCHEMBL19141233 0.76 CYP1A2 (0.52) LTA4HCYP1A2CYP2C9CYP2C19NR5A1
SCHEMBL2759077 0.75 PLA2G2A (0.55) LTA4HNR5A1TSHRPLA2G2ACYP3A4
SCHEMBL6291598 0.73 LTA4H (0.41) LTA4HCYP1A2CYP2C9CYP2C19NR5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 LTA4H 1866/4885CYP1A2 945/4885CYP2C9 1864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.